Laparoscopic bowel resection combined with infliximab treatment (LaRIC) versus infliximab for terminal ileitis in Crohn’s disease: a randomised, controlled, open-label trial

INTRODUCTION: Crohn’s disease is a chronic inflammatory disease of the gastrointestinal tract with an increasing incidence and prevalence worldwide. The early use of anti-­tumour necrosis factor agents, such as infliximab, in patients with an aggressive form of Crohn’s disease has become part of rou...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Xiuxiu, Feng, Tienan, Yang, Yang, Shi, Yuan, Jing, Ran, Liu, Sailiang, Luo, Yang, Qiao, Yuqi, Zhong, Ming, Yu, Minhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670938/
https://www.ncbi.nlm.nih.gov/pubmed/33199421
http://dx.doi.org/10.1136/bmjopen-2020-038429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670938/
https://www.ncbi.nlm.nih.gov/pubmed/33199421
http://dx.doi.org/10.1136/bmjopen-2020-038429

Ejemplares similares